In recent studies, CD24 has attracted attention as a promising strategy for treating COVID-19 due to its known anti-inflammatory action, especially soluble CD24 may reduce COVID-19-associated systemic immunopathology [119]. The gene discussed is CD24; the disease is COVID-19.